List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #55,001 to #55,050.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Tyrosine kinase inhibitor → Protein kinase inhibitor
  2. Tyrosine kinase inhibitors → Protein kinase inhibitor
  3. Tyrosine kinases → Tyrosine kinase
  4. Tyrosine phosphatase → Protein tyrosine phosphatase
  5. Tyrosinemia type 1 → Tyrosinemia
  6. Tyrosines → Tyrosine
  7. Tysabri → Natalizumab
  8. Tyzeka → Telbivudine
  9. Tzanck smear → Tzanck test
  10. Tæniæ → Taenia coli
  11. Tγ-lymphoproliferative disorder → T-cell large granular lymphocyte leukemia
  12. U-235 → Uranium-235
  13. U-Tri-Lone → Triamcinolone
  14. U.S. Agency for International Development → United States Agency for International Development
  15. U.S. Department of Agriculture → United States Department of Agriculture
  16. U.S. Department of Health and Human Services → United States Department of Health and Human Services
  17. U.S. Food and Drug Administration → Food and Drug Administration
  18. U.S. National Institutes of Health → National Institutes of Health
  19. U.S. National Library of Medicine → United States National Library of Medicine
  20. U.S. Public Health Service → United states public health service
  21. U.S. customary unit → United States customary units
  22. U.S. drug regulation → Regulation of therapeutic goods#United States
  23. U. urealyticum → Ureaplasma urealyticum
  24. U. urealyticum biovar 1 → Ureaplasma urealyticum
  25. U. urealyticum biovar 2 → Ureaplasma urealyticum
  26. U.parvum → Ureaplasma urealyticum
  27. U.urealyticum → Ureaplasma urealyticum
  28. U.urealyticum biovar 1 → Ureaplasma urealyticum
  29. U4EA → 4-Methyl-aminorex
  30. UA → Unstable angina / non ST elevation myocardial infarction
  31. UA/NSTEMI ACC/AHA guidelines for immediate management → Unstable angina / non ST elevation myocardial infarction ACC/AHA guidelines for immediate management
  32. UA/NSTEMI inhibitors of RAS → Unstable angina / non ST elevation myocardial infarction inhibitors of RAS
  33. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines Nonsteroidal Anti-Inflammatory Drugs → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines nonsteroidal anti-inflammatory drugs
  34. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines antioxidant vitamins and folic acid
  35. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines depression → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines depression
  36. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for CCB → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for calcium channel blockers
  37. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for Physical Activity → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for physical activity
  38. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for antiplatelet therapy
  39. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers
  40. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for blood pressure control
  41. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus
  42. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for inhibitors of the RAS
  43. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for lipid management
  44. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for nitroglycerin
  45. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for smoking cessation
  46. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for warfarin therapy
  47. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for weight management
  48. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines hormone therapy
  49. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines influenza vaccination
  50. UA/NSTEMI long-term medical therapy and secondary prevention ACC/AHA guidelines patient education → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines patient education

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"